-+ 0.00%
-+ 0.00%
-+ 0.00%

2026 ASH ORAL PRESENTATION | INNOCARE ANNOUNCES PHASE III RESULTS OF ORELABRUTINIB IN ITP STUDY MEET PRIMARY ENDPOINT

Reuters·11/05/2026 10:34:39

Please log in to view news